Abiopharma

🔍 Sousa Mauad Bruno (Director)

Company: Aura Minerals Inc. (AUGO)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Sold 280,000 shares of Common Shares at $81.67 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 168,765.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 12,895 shares of Brazilian Depository Receipts (Derivative)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 15,634,789.00 | transaction_form_type: 4 | Footnotes: F2, F3, F2, F2

Footnotes:

• F1: The price reported is a weighted average price. These shares were bought in one transaction at price of $81.67. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4;
• F2: Brazilian Depositary Receipts ("BDR") are certificates representing Common Shares, no par value ("Common Shares") of the Issuer. Three BDRs represent one Common Share of the Issuer.
• F3: The price reported is a weighted average price. These BDRs were sold in multiple transactions at prices ranging from $27.55 to $28.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of BDRs sold at each separate price within the ranges set forth in footnote (3) to this Form 4. The weighted average price, R$144.71 Brazilian reais ("BRL") per BDR, has been converted to U.S. dollars ("USD") using the Banco Central do Brasil's conversion rate as of August 19, 2026.
• REMARKS: Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.